Utilizing
somatic cell hybrids we now sublocalized the marker D22Slf3 within the band region 22q12-13.1, thus placing it in the vicinity of the gene for the platelet derived growth factor (PDGFB). A physical map was established for the regions surrounding the PDGFB gene and the D22Sl6 marker. By means of pulsed-field gel electrophoresis (PFGE) D22S16 and PDGFB were found to be physically linked within 900 kb. We also identified two CpG clusters bordering the PDGFB gene. For the enzyme NotI, a variation of the PDGFB restriction pattern was found between different individuals. PFGE analysis of the two loci (PDFGB and D22S16) failed to identify major rearrangements in meningioma.
INTRODUCTION
Chromosome 22 contains only 1.9% of the total haploid human genome -57,000 kb (Rouleau et al., 1989) . Despite its small size, chromosome 22 is involved in numerous inherited and acquired diseases (for review, see Kaplan et aZ., 1987) . Accordingly, a physical map of chromosome 22 will contribute to the analysis of disorder-related rearrangements (e.g., in meningioma). By means of restriction fragment length polymorphisms (RFLPs), genetic mapping has provided the gene location for hereditary disorders such as Huntington's disease and cystic fibrosis (Gusella et al., 1983; White et al., 1985) . However, genetic mapping requires polymorphic probes and informative disease pedigrees. ' For meningiomas only a few kindreds have been described and map resolution is limited by availability of useful RFLP probes. Even until most recently, available RFLP probes have been only adequate to assign the candidate recessive oncogene to a relatively large 20-CM region between 22q12.3 and qter (Dumanski et al., 1987; Meese et al., 1987; Dumanski et al., 1990) .
The technique of pulsed-field gel electrophoresis (PFGE) (Carle and Olson, 1984; Schwartz and Cantor, 1984 ) offers a powerful approach to generate precise mapping information that does not depend upon recombination frequency. This is especially important for chromosome 22 where the genetic map (97 CM) exceeds the calculated physical length (60 CM) by more than 60%, indicating a high recombination frequency (Rouleau et al, 1989) . Using PFGE, only a limited number of probes (e.g., 100 adjacent fragments of 500 kb) would be required for establishing a long-range restriction map spanning the entire chromosome 22.
As a starting point for the physical map within the meningioma chromosomal region we chose the protooncogene PDGFB (22q12.3-13.1), which is the most proximal marker to be lost in meningioma with a (46,22q-) karyotype (Dumanski et al., 1987 (Dumanski et al., , 1990 . Using a panel of somatic cell hybrids the marker D22S16 was localized to the same band region. Longrange restriction mapping is reported for both sequences (D22S16 and PDGFB), placing both loci on a restriction fragment of 900 kb. Utilizing this mapping information we have studied possible rearrangements of PDGFB and D22S16 in meningioma.
MATERIALS AND METHODS

Cell Culture
Meningioma tumor specimens and skin biopsies from the same patients were obtained freshly after and Table 2 ). PCR products were electrophoresed in 1.4% agarose gels and stained with ethidium bromide.
Each of the multiplex reactions was optimized for Mg2+ concentration over the range of 3 to 9 mM MgCl, at 1.5 mA4 intervals (data not shown). The relatively high optimum Mg2+ concentrations for these reactions are due to the high nucleotide concentrations used (Kogan et al., 1987) which favor multiplexing (Chamberlain et ab, 1988 ). The somatic cell hybrid panel was derived using alanosine and adenine selection for APRT+ phenotype on an uprt-A9 mouse cell line background (Callen, 1986 ). The human chromosomes were derived from cell lines containing various translocations or deletions of chromosome 16. The human APRT gene maps to the distal tip of the long arm of chromosome 16 and all but one of the hybrids tested contain this locus. These hybrids therefore have breakpoints that map either on the short arm or proximal to the APRT locus on the long arm. The one hybrid that does not contain APRT is CY3, which was constructed by selection of the HPRT gene present on the X chromosome, as the chromosome 16 material in this hybrid originated from an X;16 translocation (Callen, 1986) .
The PCR marker for the APRT gene was used as an internal positive control to verify negative results from the analysis of other loci. Two APRT PCR markers were designed utilizing the same forward primer but different reverse primers, and generated a 200-or 403-bp PCR product (Table 1) . This allowed for greater flexibility in the design of multiplex reactions (Table 2) . Additional STSs were chosen from available DNA sequences of genes known to map to chromosome 16 and, where possible, from evenly spaced intervals over the length of the chromosome. In those cases where only cDNA sequence was available, primer sequences were synthesized from the 3' untranslated region in an attempt to avoid spanning introns.
In all but one instance the size of the PCR product matched the published nucleotide sequence. The CR3A product was predicted to be 569 bp but was found to give a 490-bp product. This gene mapped to the 16pll-qll region, which is consistent with its previous localization (Corbi et cd., 1988) . The sequence between the two PCR primers at this locus contains about 200 bp which comprise mainly GT dinucleotide repeats. Such repeats are frequently polymorphic (Weber and May, 1989 ) and this may ac- and 2B). Given the fact that the restriction sites for CM, NotI, and Sac11 are clustered and that the CZuI sites are situated outside the SfiI sites, the Not1 sites and the Sac11 sites should also fall outside the SfiI fragment. This extrapolation was verified by a @I/ Not1 and a SfiI/SacII double digest leaving the size of the SfiI fragment unaltered (Fig. 2B) . Next to the Sac11 band at 200 kb an additional Sac11 band at 140 kb was found. The Sac11 pattern remains unaltered even by an extended digestion with increased amounts of restriction enzyme, suggesting hypermethylation of Sac11 sites. The smaller Sac11 fragment at 140 kb remains unaltered by subsequent digestion with Not1 or CM, indicating a Sac11 site within the 200-kb fragment that is flanked by the SocII/CluI/NotI cluster. The size of the NurI fragments appears to be unchanged by subsequent restriction with SfiI, placing the restriction sites for NurI between the SfiI fragment and the ClaI/NotI/SucII cluster. These results are summarized in the map shown in Fig. 2D .
Large-Scale Restriction
Mapping for PDGFB
To map the PDGFB region we used the same rare cutting endonucleases as for the physical mapping of D22S16. In most cases, we obtained restriction fragments in the size range between 110 and 130 kb, suggestive of two clusters of CpG islands (Fig. 3) mer, 1987). HTF islands contain a high frequency of unmethylated CpG dinucleotides and, therefore, a higher density of restriction sites for rare cutting enzymes. These results were confirmed by a combination of double digests: The fragment sizes obtained in a single restriction are not significantly reduced by subsequent restriction with a second enzyme, placing the recognition sites for the used enzymes close to each other (Fig. 2C) .
To ensure that both enzymes were active in the double digest each experiment was accompanied by two single digests using the enzymes separately. In addition, all blots were hybridized with both probes. A representative blot is shown in Figs. 2B and 2C. Following hybridization with PDGFB the probe was removed, and the blot was rehybridized with the D22S16 probe. As demonstrated in Fig. 2C , PDGFB fragments of similar size have been found in the single Not1 and SfiI digests and in the NotI/SfiI double digests. Following rehybridization with D22S16, the size of the Not1 fragment (200 kb) was reduced to 50 kb in a NotI/SfiI double digest. A band of 50 kb was also found following the single SfiI digest (Fig. 4B) .
Finally, a variation of the Not1 restriction pattern has been found between different individuals. As demonstrated in Fig. 4 , next to the 130-kb band, we found an additional 450-kb signal in some lymphocyte samples. While the 130-kb band was observed in all individuals, the additional band was only found in 7 of 11 individuals.
In none of the tested samples did we detect a single 450-kb band.
Variation of the Not1 restriction pattern has already been described for other probes such as pmetH in which case the variation is due to a site polymorphism (Julier and White, 1988; Collins et al., 1987) . It remains to be shown whether the PDGFB variation reflects a point mutation, a major rearrangement, or a difference in the methylation pattern.
Physical Linkage of PDGFB and D22Sl6
To physically link the gene PDGFB and the marker D22S16, we used extended pulsed times and conditions for partial restriction digestion (Fig. 5) . Restriction fragments containing the two loci were identified by sequential hybridization to both probes. The restriction endonucleases NotI, SfiI, and ClaI did not produce DNA fragments long enough to be recognized by the two probes. However, the enzyme NruI revealed two fragments (900 and 1300 kb) that hybridize to D22S16 and PDGFB, thereby, indicating the maximum distance for these two markers (Fig. 5) . Linkage was also found using the enzyme MuI, confirming the results obtained by NruI digest. Smaller NruI fragments that were unique to each probe in- elude a 400-kb fragment for D22S16 and a fragment at 500 kb for PDGFB (data not shown).
PFGE Analysis of Meningiomm
The flanking regions of PDGFB and D22S16 have been analyzed in cell cultures from six meningiomas. Following restriction with NotI, PDGFB fragments of identical sizes have been identified in meningioma and fibroblasts (Fig. 6) , as well as in dura mater and arachnoid DNA (data not shown). Arachnoid cells are considered to be the cells of origin for meningioma. Lymphocyte DNA reveals a slightly different methylation status. Following hybridization with D22S16, an identical pattern was demonstrated in all analyzed cell types. Two additional enzymes (ClaI and SacII) also failed to demonstrate specific alterations in meningiomas.
DISCUSSION
The migration of DNA molecules in PFGE gels depends on a number of variables (e.g., switching time, voltage gradient, DNA concentration, etc.) and can easily be modified by even small variations of one of the parameters (Birren et al., 1988) . For example, the occurrence of a peak in the size distribution of restriction fragments may result in altered migration due to local overloading of the gel. Therefore, we included several controls for each experiment. First, all experiments were repeated three times with DNA from different individuals. Second, as mentioned above, in cases where the fragment size remained unaltered by subsequent digest with another enzyme, we rehybridized with a second unrelated probe. Finally, the order of the restriction enzymes used in the double digest was reversed (e.g., the results of a CZ.oI/SacII digest were verified by a SucII/CZuI restriction).
As a starting point for the large scale restriction map of chromosome 22, we have chosen the proto-oncogene PDGFB. Surprisingly, relatively small fragments have been identified even for enzymes (e.g., Not1 that usually generate significantly larger fragments (Barlow and Lehrach, 1987) ). Using a combination of single and double digests we identified two CpG clusters flanking the PDGFB gene. Using the GeneBank sequence data, Gardiner-Garden and Frommer (1987) analyzed the distribution of HTF islands with respect to gene termini. They identified CpG islands predominantly at the 5' end of many analyzed genes including PDGFB. In a few instances both 5' and 3' CpG islands were found. Our results support the notion that an HTF island is present 3' to the PDGFB gene. However, the possibility cannot yet be excluded that this HTF island may represent a 5' CpG cluster related to an as yet unidentified transcription unit bordering the 3' end of the PDGFB gene.
We report here the extension of the physical map surrounding the PDGFB gene. The marker D22S16 was sublocalized to the band region 22q13.1 utilizing a hybrid mapping panel. By means of PFGE D22S16 was shown to be situated within 900 kb of the PDGFB gene. In addition, we studied meningiomas using these two probes in PFGE experiments. Neither PDGFB nor D22S16 detected any structural rearrangement in meningioma.
Our results should assist in localizing the region of the putative suppressor gene in meningioma. Together with the recently published physical map of the band region 22qll (McDermid et aZ., 1989) , our data for the region 22q12.3-13.1 contribute to the development of a complete physical map of chromosome 22. 
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